Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US9700530 | SPIL | Capsule dosage form of metoprolol succinate |
Jul, 2035
(12 years from now) | |
US9504655 | SPIL | Capsule dosage form of metoprolol succinate |
Jul, 2035
(12 years from now) |
Market Authorisation Date: 26 January, 2018
Treatment: NA
Dosage: CAPSULE, EXTENDED RELEASE;ORAL
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic